Seattle Genetics buys manufacturing facility from Bristol-Myers

|About: Seattle Genetics, Inc. (SGEN)|By:, SA News Editor

Seattle Genetics (NASDAQ:SGEN) agrees to purchase a Bothell, WA-based pharmaceutical manufacturing facility from Bristol-Myers Squibb for an undisclosed sum. The 51,000 sq.ft. site was constructed in 2014. SGEN intends to use it for antibody production.

Subscribe for full text news in your inbox